Immune Disease Institute

Polygenic Diseases on the Rise

An Explanation Based on "Population Mixing"
In an era marked by rapid mobility of populations and increased social and economic interaction among diverse groups, the inevitable trend towards globalization has biological as well as economic and cultural consequences, states Senior Investigator Chester Alper, M.D. more >>

Rao Lab Finds Key to T Cell's Shifting Proteome When immune T cells encounter the enemy-a virus, bacteria or other foreign invader-they transform from a state of quiet readiness to fully armed fighters. This process of T cell activation, which occurs in a day or less, requires the cell to produce a host of new proteins to fill its arsenal. more >>
IDI and GlaxoSmithKline Kick Off Research Alliance The Immune Disease Institute and GlaxoSmithKline (GSK) are gearing up to launch their five-year, $25 million research collaboration, aimed at speeding the development of new medicines to fight autoimmune and inflammatory disease. more >>
Immune Cells Kill Foes By Disrupting Mitochondria Two Ways "This work gives us a new understanding of a major T cell defense pathway," Lieberman says. The results appeared in the May 16th issue of Cell. more >>
© 2004 The Immune Disease Institute All rights reserved. 800 Huntington Avenue, Boston, Massachusetts, 02115

CBRI has, in order to reflect its principal research programs, taken the new name of Immune Disease Institute. To celebrate this important milestone in our history, we are creating a new web site. We look forward to sharing it with you in the fall.